Premium
Cannabis potency in Europe
Author(s) -
KING LESLIE A.,
CARPENTIER CHLOÉ,
GRIFFITHS PAUL
Publication year - 2005
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/j.1360-0443.2005.001137.x
Subject(s) - cannabis , potency , effects of cannabis , delta 9 tetrahydrocannabinol , dronabinol , medicine , psychology , pharmacology , traditional medicine , cannabidiol , psychiatry , cannabinoid , chemistry , biochemistry , in vitro , receptor
There has been much recent interest in the possibility that the concentration of D 9 -tetrahydrocannabinol (THC), the active principle in cannabis, is now greater than it was. If pronouncements in the popular media are to be believed, the THC content (potency) is 10 or 20 times the levels of only a generation ago, giving apparent cause for concern about increased problems. The more cynical might comment that this is also a convenient rallying cry for those against an increasingly permissive attitude to cannabis use. But to what extent do the available data justify this fear? If one begins to explore the issue in more detail, it becomes evident that concerns about high potency cannabis are by no means new, and the reality appears both less alarming and more complex.